The persistent global challenge of skin cancer, primarily driven by excessive exposure to ultraviolet (UV) radiation, underscores the critical importance of daily sun protection. Despite widespread dermatological recommendations emphasizing consistent sunscreen application as a fundamental preventative measure, significant segments of the population continue to forgo this vital practice. This discrepancy often stems from a combination of factors, notably the aesthetic shortcomings of many commercially available sunscreens, particularly those formulated with mineral active ingredients. A recent groundbreaking study by researchers at UCLA Health’s Jonsson Comprehensive Cancer Center offers a compelling solution, demonstrating an innovative approach to mineral sunscreen formulation that promises to enhance user compliance and, consequently, public health outcomes.
Skin cancer remains the most prevalent malignancy in the United States, with millions of new cases diagnosed annually. While basal cell carcinoma and squamous cell carcinoma are the most common forms, melanoma, though less frequent, accounts for the vast majority of skin cancer-related deaths due to its aggressive nature and propensity for metastasis. The scientific consensus unequivocally links UV radiation exposure—from both the sun and artificial sources like tanning beds—to cellular DNA damage, which can precipitate cancerous transformations. Daily sunscreen use effectively mitigates this risk by forming a protective barrier against harmful UVA and UVB rays. UVA radiation contributes significantly to premature skin aging, characterized by wrinkles, fine lines, and hyperpigmentation, while UVB rays are the primary culprits behind sunburn and play a dominant role in the development of most skin cancers.
Historically, the market has offered two principal categories of sunscreens: chemical and mineral. Chemical sunscreens absorb UV radiation through organic compounds that convert it into heat, while mineral sunscreens, containing zinc oxide or titanium dioxide, physically block and scatter UV light. Dermatologists frequently endorse mineral formulations, especially for individuals with sensitive skin, rosacea, acne-prone complexions, or those who prefer non-chemical alternatives, owing to their generally lower potential for irritation. Furthermore, the U.S. Food and Drug Administration (FDA) has affirmed zinc oxide as a safe and effective broad-spectrum UV filter. However, the Achilles’ heel of traditional mineral sunscreens has long been their tendency to leave a visible white or grayish residue on the skin, a phenomenon often referred to as a "white cast." This cosmetic drawback is a major deterrent for many potential users, hindering consistent application and undermining public health campaigns advocating for daily photoprotection.
The aesthetic challenge posed by mineral sunscreens is particularly acute for individuals with darker skin tones, where the chalky film becomes far more conspicuous. This issue contributes to a significant disparity in sunscreen usage rates, with people of color often less inclined to incorporate sun protection into their daily routines. The consequences of this disparity are stark and severe: although melanoma incidence is lower in populations with darker skin, research indicates that when diagnosed, it is frequently discovered at later, more advanced stages, leading to a considerably higher mortality rate compared to Caucasians. This delay in diagnosis is partly attributed to reduced awareness of skin cancer risks in these communities, coupled with the perception that sunscreen is less necessary for darker complexions, and exacerbated by the undesirable appearance of conventional mineral formulas. Addressing this aesthetic barrier is therefore not merely a cosmetic concern but a crucial step towards achieving greater equity in skin cancer prevention and outcomes.
Recognizing this critical unmet need, a research team spearheaded by scientists at UCLA has engineered a novel solution that bypasses the need for entirely new chemical compounds. Instead, their innovative approach focuses on fundamentally altering the physical morphology of the zinc oxide particles themselves. Traditional zinc oxide utilized in mineral sunscreens typically comprises very small, roughly spherical nanoparticles. These particles, while effective at UV blocking, possess an inherent tendency to clump together when dispersed in a lotion or cream. This aggregation not only compromises the stability of the formulation over time but also significantly contributes to the scattering of visible light, which manifests as the dreaded white or gray film on the skin’s surface.
The UCLA researchers, led by senior author Paul S. Weiss, a distinguished professor across multiple disciplines including chemistry & biochemistry, bioengineering, and materials science & engineering, and an investigator in the UCLA Health Jonsson Comprehensive Cancer Center, developed a unique methodology to reshape zinc oxide into microscopic, four-armed structures. These intricate particles are aptly termed "tetrapods." Unlike their conventional spherical counterparts, these tetrapodal structures are produced through a patented high-temperature flame process, yielding particles that are significantly larger and possess a distinct three-dimensional architecture. This innovative design fundamentally alters how the particles interact with each other and with light.
The key to the tetrapods’ efficacy lies in their inability to pack tightly or aggregate into dense clumps. As explained by first author AJ Addae, a UCLA chemical biology doctoral candidate and cosmetic science entrepreneur whose personal frustrations with existing mineral sunscreens fueled much of the research, "Because of their structure, these tetrapod-shaped particles have standoffs and form porous networks instead of collapsing into clumps. They can’t pack tightly and aggregate, so they stay evenly distributed in the sunscreen." This inherent resistance to clumping ensures a more uniform dispersion of the active ingredient throughout the formulation, leading to enhanced stability and a more consistent, aesthetically pleasing application.
In rigorous comparative studies, the research team pitted the novel tetrapod-shaped zinc oxide against conventional spherical zinc oxide nanoparticles. The results, published in the esteemed journal ACS Materials Letters, underscored several compelling advantages of the new architecture. When incorporated into sunscreen formulations at identical concentrations, the tetrapod-based creams consistently achieved a sun protection factor (SPF) of approximately 30, a level comparable to the efficacy provided by standard mineral sunscreens and widely recommended by dermatologists for daily use.
Beyond maintaining robust UV protection, the tetrapod formulations demonstrated superior stability over time. Unlike conventional mineral sunscreens that can sometimes exhibit signs of separation or an undesirable thickening, the lotions containing the new zinc oxide particles remained remarkably consistent in their texture and integrity. However, the most striking and immediately visible improvement was in the particles’ interaction with visible light. Through both laboratory experiments and controlled applications on human skin, the tetrapod sunscreen produced a significantly warmer and more natural appearance, seamlessly blending with various skin tones without imparting the stark white or grayish cast traditionally associated with zinc oxide. Crucially, this enhanced aesthetic was achieved without the addition of pigments or specialized coatings, relying solely on the intrinsic structural properties of the redesigned particles. Addae recounted the pivotal moment: "When I spread it on my own skin, I didn’t get that white cast I usually see with zinc oxide. That was the moment I realized this could really work." Professor Weiss added, "What surprised us was how quickly it worked. The very first formulations already showed a visible difference."
This interdisciplinary triumph, bridging materials science, chemistry, bioengineering, and cancer research, highlights how fundamental advancements in particle engineering can address practical, real-world barriers to public health. The journey from laboratory innovation to widespread commercial availability typically involves extensive additional testing, regulatory approvals, and manufacturing scale-up. However, the initial findings unequivocally demonstrate the profound potential of this technology to transform the landscape of sun protection. The researchers are now actively collaborating with the UCLA Health department of dermatology, including the specialized Skin of Color Clinic, to further investigate how these tetrapod particles interact with the skin microbiome and to advance their development towards practical, real-world applications.
The implications of this breakthrough extend far beyond mere cosmetic enhancement. By making mineral sunscreens more appealing and comfortable to wear, particularly for individuals who have historically struggled with the aesthetic limitations of existing products, this innovation has the power to dramatically increase consistent sunscreen use across diverse populations. As Addae succinctly articulated, "The best sunscreen is the one people will actually use. If zinc oxide can be made to look better on more skin tones without sacrificing protection, it could help more people protect themselves from the sun’s most dangerous effects." Ultimately, this scientific advancement represents a significant stride toward a future where effective sun protection is universally accessible and aesthetically agreeable, thereby playing a pivotal role in reducing the global burden of skin cancer and fostering healthier skin for all.
(Additional authors contributing to this study included Jennifer Uyanga and Addae’s thesis co-advisor Professor Justin Carman from UCLA chemistry, alongside Professor Yogendra Kumar Mishra from the University of Southern Denmark. Financial support for this research was provided in part by the National Science Foundation, the Challenge Initiative at UCLA, and a Sigma Xi IFoRE Grant-in-Aid.)
About the Author
